Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A pharmaceutical manufacturer

Etymologies

Sorry, no etymologies found.

Examples

  • Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.

    WN.com - Financial News

  • Vyvanse is the first oral ADHD stimulant with published data that demonstrated significant ADHD symptom improvement from 1.5 hours up to 13 hours after administration in Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's ...

    WN.com - Business News

  • And how much damage could this do to the drug market -- the drugmaker, that is, in general?

    CNN Transcript Nov 15, 2004

  • The drugmaker was the biggest percentage decliner on the S&P 500.

    Market flat, pares losses from jobless claims - Yahoo! Finance

  • The drugmaker was the largest shareholder with 18 percent of Quest as of March 2009, according to data compiled by Bloomberg.

  • The Swiss drugmaker, which is Europe's second-largest after Roche Holding AG, also would be interested in biotechnology companies with some products in development, Jimenez said.

    BusinessWeek.com -- Top News

  • The biotech drugmaker, which is moving forward on talks with suitor Sanofi-Aventis, also trimmed its outlook for 2011 as it continues recovering from manufacturing problems with its best-selling drugs.

    Genzyme expects profit, revenue boost in 4th qtr - Yahoo! Finance

  • The vote deals a major blow to the Mountainview, Calif., drugmaker, which is racing to market the first new U.S. prescription weight loss drug in over a decade.

    CBS 2 - KCAL 9 - Los Angeles - Southern California - LA Breaking News, Weather, Traffic, Sports

  • The debt-laden Australian drugmaker, which is the target of a $648 million bid from South

    AustralianIT.com.au | Top Stories

  • CYPB.O rejected a $6-per-share cash offer to acquire the drugmaker, which is in talks with a third party.

    Reuters: Top News

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.